Jefferies Group’s BeOne Medicines Ltd ONC Stock Holding History

Jefferies Group’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-13,700	Closed	-$1.69M	–	2141
2020 Q1	$1.69M	Sell	13,700 -16,800	-55%	-$2.63M	0.02%	761
2019 Q4	$5.06M	Sell	30,500 -2,800	-8%	-$465K	0.04%	509
2019 Q3	$4.08M	Buy	+33,300	New	+$4.42M	0.03%	632

Other funds holding ONC

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Jefferies Group's ONC Position: Q2 2020 in Review

Jefferies Group sold out of BeOne Medicines Ltd (ONC) in Q2 2020, closing a stake of 16,000 shares — an estimated $1.97M sold.

Jefferies Group first reported a position in ONC in Q4 2017 and held it in 7 quarters. The position peaked at $1.97M in Q1 2020. 220 funds tracked by Wall St. Rank hold ONC as of Q2 2020.

Jefferies Group reported no remaining BeOne Medicines Ltd position as of Q2 2020 after selling out during the quarter.
Jefferies Group sold 16,000 BeOne Medicines Ltd shares in Q2 2020, an estimated $1.97M.
Jefferies Group first reported a position in BeOne Medicines Ltd in Q4 2017 and held it in 7 quarters.
Jefferies Group's BeOne Medicines Ltd position peaked at $1.97M in Q1 2020.
220 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2020.

Based on Jefferies Group's 13F filing for Q2 2020, filed 14 Aug 2020.